Advertisement
Screener

SeaStar Medical Holding Corp (ICU) Overview

SeaStar Medical Holding Corp (ICU) Overview

  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.18; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual -0.44; Beat / miss (m).
  • 1 Jul 2024: Period ending 30 Sept 2024; Estimate (m); Actual -1.10; Beat / miss (m).
  • 1 Apr 2024: Period ending 30 Jun 2024; Estimate (m); Actual -1.03; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$2.10$2.69$3.44$4.40$5.62$7.192025-09-292026-09-29$2.10$9.12$39.59$171.92$746.55$3,241.872021-09-292026-09-29$2.10$9.12$39.59$171.92$746.55$3,241.872021-03-182026-09-29$2.10$9.12$39.59$171.92$746.55$3,241.872021-03-182026-09-29$2.10$9.12$39.59$171.92$746.55$3,241.872021-03-182026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$3.56
Previous close
$3.40
Change
$0.16
Change (%)
4.71%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

ICU
+48.33%
S&P 500
(m)

1 year

ICU
-40.67%
S&P 500
(m)

3 years

ICU
-94.61%
S&P 500
(m)

5 years

ICU
-99.86%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2025 ○ Estimate (m) ● Actual -0.18

-4.81-3.61-2.41-1.200.0031 Mar 2024: estimate (m); actual -4.7331 Mar 2024(m)30 Jun 2024: estimate (m); actual -1.0330 Jun 2024(m)30 Sept 2024: estimate (m); actual -1.1030 Sept 2024(m)31 Mar 2025: estimate (m); actual -0.4431 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.1830 Jun 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202530 Jun 2025(m)-0.18(m)(m)
1 Jan 202531 Mar 2025(m)-0.44(m)(m)
1 Jul 202430 Sept 2024(m)-1.10(m)(m)
1 Apr 202430 Jun 2024(m)-1.03(m)(m)
1 Jan 202431 Mar 2024(m)-4.73(m)(m)

31 Dec 2024 ○ Estimate (m) ● Actual -6.63

-30.34-22.87-15.39-7.92-0.4531 Dec 2021: estimate (m); actual -0.6331 Dec 2021(m)31 Dec 2022: estimate (m); actual -1.4831 Dec 2022(m)31 Dec 2023: estimate (m); actual -30.2631 Dec 2023(m)31 Dec 2024: estimate (m); actual -6.6331 Dec 2024(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202431 Dec 2024(m)-6.63(m)(m)
1 Jan 202331 Dec 2023(m)-30.26(m)(m)
1 Jan 202231 Dec 2022(m)-1.48(m)(m)
1 Jan 202131 Dec 2021(m)-0.63(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 0.61M ■ Earnings -3.73M — Profit margin -606.50%

-4.25M-1898.3%-2.46M-1467.3%-0.66M-1036.4%1.14M-605.5%30 Sept 2025: revenue 0.18M; earnings -3.47M; profit margin -1897.27%30 Sept 202531 Dec 2025: revenue 0.42M*; earnings -2.90M*; profit margin -691.43%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 0.49M; earnings -3.52M; profit margin -711.31%31 Mar 202630 Jun 2026: revenue 0.61M; earnings -3.73M; profit margin -606.50%30 Jun 2026

31 Dec 2025 ■ Revenue 1.23M ■ Earnings -12.15M — Profit margin -984.60%

-29.53M-18393.6%-18.18M-12590.3%-6.82M-6786.9%4.53M-983.6%31 Dec 2023: revenue 0.00M; earnings -26.23M; profit margin (m)31 Dec 202331 Dec 2024: revenue 0.14M; earnings -24.83M; profit margin -18392.59%31 Dec 202431 Dec 2025: revenue 1.23M; earnings -12.15M; profit margin -984.60%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$3.56(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$3.56High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning ICU

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-13.63M
Profit margin
-795.50%
Return on assets · 12 month
-160.02%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
43.04K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
0.85%*
Total return · month
15.21%*
Total return · quarter
0.28%*
Total return · half year
29.93%*
Total return · year to date
48.33%*
Total return · 1 year
-40.67%*
Total return · 3 years
-94.61%*
Total return · 5 years
-99.86%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$1.71M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

SeaStar Medical Holding Corp Overview

View more →

(m)

(m)

SEC CIK
1831868
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
3513 BRIGHTON BLVD, SUITE 410, DENVER, Colorado, 80216, United States
Fiscal year end
1231
Phone
844-427-8100

Similar stocks

Stock NameCountryMarket CapPE Ratio
CERENOME, INC. (CNSY)United States$0.014B
Modular Medical, Inc. (MODD)United States$0.018B-0.88
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
Picard Medical, Inc. (PMI)United States$0.011B-0.01
FEMASYS INC (FEMY)United States$0.020B-1.07
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32